FDA Investigator Patrick B Cummings

Patrick B Cummings has inspections in 4 countries as of 06 Oct 2023. Patrick B Cummings has collaborated with a combinined 3519 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
83
Last Inspection Date:
06 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100008091
Country:
United States of America, Germany, United Kingdom of Great Britain and Northern Ireland, Ireland
Co-Investigator(s):
A Williams, Alanna Lmussawwir Bias, Alexandra A Carrico, Amber M Capello Jones, Amina Bashir, Amy S Graf, Andrace Lde Yampert, Andrea D Swingle, Andrew H Paeng, Anthony J Ladner, Anthony R Petriella, Antonio M Hampton, April L Young, Art O Czabaniuk, Ava M Bowman, Barbara D Bennett, Bei Y He, Benjamin J Smith, Bernard P Heidt, Beverley A Phillips, Bhakti Petigara Harp, Brandi N Mcgrady, Brian J Davis, Brian M Campbell, Brian P Hendrickson, Brian P Putz, Brian R Yaun, Brittany M Lowe, Bruce, Byungja E Marciante, Calvin K Cook, Caroline H Le, Catherine J Laufmann, CDR Kimberly Y Martin, CDR Sean T Creighton, Charles E Frelix, Charles I Ann, Charles L Zhou, Charles M Spyr, Charles M Sypr, Chelsea J Falkowski, Constantin Y Philopoulos, Corrine M Carter, Cynthia L Aycock, Cynthia Li, Daniel J Gorski, Danny Tuntevski, David A Paterson, David H Smith, David J Gasparovich, David J Gsparovich, David P Vanhouten, Dawn C Olenjack, Debara R Reese, Debara Reese, Denise L Burosh, Dennis E Guilfoyle, PhD, Dina A Tallman, Donald C Obenhuber, PhD, Dorothy W Lee, Downer, Edwardstine J Reese, Ellen J Tave, Emest F Bizjak, Emily J Orban, Eric S Pittman, Erin M Miller, Frank Wackes, Gary Durbiel Goldner, George G Calafactor, Gregory A Berg, Hans T Meyers, Harperd, Ifueko Osemwota, Ivan E Reyes, James A Lane, James E Szelc, James N Rench, Janis R Armedoriz, Jean Blackston Hill, Jean Blackstone Hill, Jeffrey A Sommers, Jeffrey D Meng, Jennifer A Kemp, Jennifer L Johnson, Jennifer R Johnson, Jennifer R Mathern, Joan A Loreng, Jocelyn M Muggli, John D Jaworski, John N Woodall, Joie A Navarrete, Joseph A Piechocki, Joseph R Strelnik, Joshua M Adams, Julia A Avery, Juliane C Lessard, Karen M Montgomery (KMM), Kathryn G Brown, Kelley L Clark, Kennita Riddick, Kimberly Lewandowski Walker, Kinh Q Mac, Kristina J Donohue, Kristina Mezin, Kristina Nastovski, L'oreal F Walker, Larry K Austin, Laureen M Geniusz, Lauren E Burke, Lauren E Priest, Lauren E Sexton, Lauren Iacono Connors, PhD, Lawton W Lum, LCDR Anastasia Mpiliafas Brown, Leigh Anne Myers, Lisa J Joseph, Lisa M Bellows, Lisa M Thursam, Luella J Rossi, Mancia R Walker, Maribeth G Grattan, Maribeth G Niesen, Marie A Fadden, Mark G Peterson, Marlon K Turner, Martin R Vowell, Meisha R Sampson, Meisha Waters, Melina Rodriguez Upton, Mercy Oyugi, Michael E Barta, Michael Shanks, MS, Michele L Forster, PhD, Miguel G Manzano, Mikhail V Ovanesov, PhD, Misty D Harvey, Monica J Wilkins, Montgomery Montgomery, Karen M, Muna Algharibeh, Myra K Casey, Nailing Zhang, Natalie A Mickelsen, DVM, Neal D Singletary, PhD, Neal D Singletony, Neali H Lucas, Norman Wong, Pablo Alcantara, Patricia A Cochran, Patricia H Dlugosz, Patsy J Domingo, Paula P Demichael, Perry H Gambrell, Qiao Y Bobo, Rafeeq A Habeeb, Ralph Jerndal, Rasha Bamieh, Raymond T Oji, Rebecca E Dombrowski, Richard T Riggie, Robert D Tollefsen, Robert G Ruff, Robert J Ham, Robert M Barbosa, Rohn R Robertson, Rosanna M Goodrich, Ryan J Benedict, Sandra A Boyd, Sargum C Sood, Shannon A Gregory, State Agency, Stefen D Mcmillan, Stephen D Eich, Stephen R Souza, Susan F Laska, MS, Susan P Bruederle, Suyang Qin, Talmane J Fisher, Tamayo C Barnes, Terrance L Scheiber, Thomas A Peter, Thomas E Friel, Thomas J Arista, Thursaml, Thuy T Nguyen, LCDR, Tina M Pawlowski, Travis S Bradley, Twana R Chandler, Vera M Anderson, Vesa Vuniqi, Victoria A Wagoner, Wayne E Seifert, William D Tingley, William G Craig, William G Nelson, William R Brubaker, Yangmin Ning, Yehualashet A Gessesse, Yumi J Hiramine

Patrick B Cummings's Documents

Publish Date Document Type Title
July, 2013 FDA 483 Cook Biotech Incorporated - Form 483, 2013-07-16
November, 2011 FDA 483 Roche Diagnostics Operations, Inc. - Form 483, 2011-11-23
September, 2012 FDA 483 Response Terumo Cardiovascular Systems Corporation - Form 483R, 2012-10-19
December, 2013 FDA 483 Rudischhauser Surgical Instruments Manufacturing GmbH - Form 483, 2013-12-04
February, 2014 FDA 483 Hill-Rom, Inc. - Form 483, 2014-02-13
July, 2013 FDA 483 Cook Incorporated - Form 483, 2013-07-30
December, 2013 FDA 483 Rominger Medizintechnik GmbH - Form 483, 2013-12-11
June, 2011 EIR DePuy Orthopaedics, Inc. - EIR, 2011-06-07
September, 2015 EIR Kindeva Drug Delivery L.P. - EIR, 2015-09-01
June, 2011 FDA 483 DePuy Orthopaedics, Inc. - Form 483, 2011-06-07
November, 2013 FDA 483 Focus Surgery, Inc. - Form 483, 2013-11-06
October, 2011 FDA 483 Hill-Rom, Inc. - Form 483, 2011-10-11
June, 2013 FDA 483 Symbios Medical Products, LLC - Form 483, 2013-06-03
February, 2011 FDA 483 Roche Insulin Delivery Systems Inc. - Form 483, 2011-02-28
July, 2010 FDA 483 Hill-Rom, Inc. - Form 483, 2010-07-06
June, 2014 FDA 483 Helmer, Inc. - Form 483, 2014-06-04
December, 2011 FDA 483 Kathy Miller, M.D. - Form 483, 2011-12-19
January, 2013 FDA 483 Hill-Rom, Inc. - Form 483, 2013-01-11
August, 2011 FDA 483 Eli Lilly and Company - Form 483, 2011-08-23
September, 2015 FDA 483 Response Kindeva Drug Delivery L.P. - Form 483R, 2015-09-15
September, 2012 FDA 483 Terumo Cardiovascular Systems Corporation - Form 483, 2012-09-28

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more